Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.63 is 14% above its 5-year average of 8.44, around the middle of its 5-year range (2.49–15.58).
As of the fiscal period ended Tuesday, June 30, 2026. 2.71% below its 12-month average of 9.90.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.63.
CURRENT RATIO
9.63
CURRENT RATIO AVG TTM
9.90
CURRENT RATIO AVG 3Y
9.80
CURRENT RATIO AVG 5Y
8.44
CURRENT RATIO AVG 10Y
9.88
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-2.71%
CURRENT VS 3Y AVG
-1.78%
CURRENT VS 5Y AVG
+14.09%
CURRENT VS 10Y AVG
-2.52%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+156.76%
vs the sector median at left
Market Cap
$3.48B
Current Ratio
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
Market Cap
$3.38B
Current Ratio
3.39
TTM Avg
3.10
3Y Avg
3.17
5Y Avg
4.31
Market Cap
$3.37B
Current Ratio
17.91
TTM Avg
1.68
3Y Avg
1.68
5Y Avg
1.68
Market Cap
$3.52B
Current Ratio
21.02
TTM Avg
15.64
3Y Avg
20.34
5Y Avg
22.11
Market Cap
$3.53B
Current Ratio
3.87
TTM Avg
5.22
3Y Avg
3.96
5Y Avg
4.18
Market Cap
$3.31B
Current Ratio
4.72
TTM Avg
21.21
3Y Avg
17.30
5Y Avg
19.05
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.43B | 9.63 | 9.90 | 9.80 | 8.44 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 3.39 | 3.10 | 3.17 | 4.31 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.37B | 17.91 | 1.68 | 1.68 | 1.68 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.52B | 21.02 | 15.64 | 20.34 | 22.11 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.53B | 3.87 | 5.22 | 3.96 | 4.18 |
| CareDx, Inc (CDNA)vs › | $3.32B | 4.58 | 3.40 | 3.98 | 4.25 |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | 4.72 | 21.21 | 17.30 | 19.05 |
| Veracyte, Inc. (VCYT)vs › | $3.55B | 9.16 | 6.44 | 5.38 | 7.95 |
Current Ratio
9.63
Quick Ratio
9.61
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.63 |
| 2026-03-31 | 7.26 |
| 2025-12-31 | 10.53 |
| 2025-09-30 | 10.02 |
| 2025-06-30 | 12.05 |
| 2025-03-31 | 15.58 |
| 2024-12-31 | 11.88 |
| 2024-09-30 | 11.93 |
| 2024-06-30 | 4.57 |
| 2024-03-31 | 7.06 |
| 2023-12-31 | 6.76 |
| 2023-09-30 | 9.50 |
| 2023-06-30 | 10.68 |
| 2023-03-31 | 7.86 |
| 2022-12-31 | 10.39 |
| 2022-09-30 | 10.17 |
| 2022-06-30 | 3.14 |
| 2022-03-31 | 2.49 |
| 2021-12-31 | 4.30 |
| 2021-09-30 | 5.17 |
| 2021-06-30 | 6.27 |
| 2021-03-31 | 7.27 |
| 2020-12-31 | 2.95 |
| 2020-09-30 | 5.06 |
| 2020-06-30 | 7.91 |
| 2020-03-31 | 4.86 |
| 2019-12-31 | 5.92 |
| 2019-09-30 | 8.88 |
| 2019-06-30 | 12.92 |
| 2019-03-31 | 17.13 |
| 2018-12-31 | 19.42 |
| 2018-09-30 | 6.61 |
| 2018-06-30 | 9.33 |
| 2018-03-31 | 15.40 |
| 2017-12-31 | 17.39 |
| 2017-09-30 | 17.20 |
| 2017-06-30 | 8.17 |
| 2017-03-31 | 15.39 |
| 2016-12-31 | 16.40 |
| 2016-09-30 | 19.66 |
| 2016-06-30 | 35.67 |
| 2016-03-31 | 4.07 |
| 2015-12-31 | 6.06 |
| 2015-09-30 | 13.37 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
| 2014-12-31 | 42.66 |
